Classification criteria of Sjogren's syndrome

被引:49
作者
Goules, Andreas V. [1 ]
Tzioufas, Athanasios G. [1 ]
Moutsopoulos, Haralampos M. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Pathophysiol, Athens 11527, Greece
关键词
Primary Sjogren's syndrome; Classification criteria; AECG criteria; SALIVARY-GLAND; DIAGNOSTIC-CRITERIA; PREVALENCE; MORTALITY; COMMUNITY; DISEASE; ANTIBODIES; UPDATE; SERIES;
D O I
10.1016/j.jaut.2014.01.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sjogren's syndrome (SS) is a chronic, systemic autoimmune disease that affects typically the exocrine glands causing mucosal dryness. Dry eyes and mouth are considered by far the most common and early symptoms of the disease but systemic complications may also occur. In 1993, the preliminary European criteria were proposed and widely accepted, consisting of both subjective and objective criteria. Almost ten years later, these classification criteria were revised by introducing more stringent rules and precise diagnostic procedures leading to the currently used American-European Consensus Group (AECG) criteria. The AECG criteria have-been largely employed to conduct epidemiologic and clinical studies of patients with SS and proved to be more specific compared to the preliminary European criteria. The recent American College of Rheumatology/Sjogren's International Collaborative Clinical Alliance (ACR/SICCA) criteria that are based exclusively on objective tests, the stringency of the AECG criteria and the potential therapeutic use of biologic agents in SS clearly set the need for new classification criteria. Whether the new diagnostic approach will further encompass subclinical and early forms of the disease remains to be addressed by the scientific community. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:42 / 45
页数:4
相关论文
共 50 条
[1]   The prevalence of rheumatic diseases in central Greece: a population survey [J].
Anagnostopoulos, Ioannis ;
Zinzaras, Elias ;
Alexiou, Ioannis ;
Papathanasiou, Aphrodite A. ;
Davas, Evangelos ;
Koutroumpas, Athanasios ;
Barouta, Georgia ;
Sakkas, Lazaros I. .
BMC MUSCULOSKELETAL DISORDERS, 2010, 11
[2]  
ANDERSON JR, 1961, LANCET, V2, P456
[3]   Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjogren Syndrome Clinical and Pathophysiologic Aspects [J].
Baimpa, Evangelia ;
Dahabreh, Issa J. ;
Voulgarelis, Michael ;
Moutsopoulos, Haralampos M. .
MEDICINE, 2009, 88 (05) :284-293
[4]  
Baldini C, 2010, ANN RHEUM DIS S3, V69, P391
[5]   Classification criteria for Sjogren's syndrome: A critical review [J].
Baldini, Chiara ;
Talarico, Rosaria ;
Tzioufas, Athanasios G. ;
Bombardieri, Stefano .
JOURNAL OF AUTOIMMUNITY, 2012, 39 (1-2) :9-14
[6]   Sjogren's syndrome and the epithelial target: A comprehensive review [J].
Barrera, M. J. ;
Bahamondes, V. ;
Sepulveda, D. ;
Quest, A. F. G. ;
Castro, I. ;
Cortes, J. ;
Aguilera, S. ;
Urzua, U. ;
Molina, C. ;
Perez, P. ;
Ewert, P. ;
Alliende, C. ;
Hermoso, M. A. ;
Gonzalez, S. ;
Leyton, C. ;
Gonzalez, M. J. .
JOURNAL OF AUTOIMMUNITY, 2013, 42 :7-18
[7]  
Binard A, 2007, CLIN EXP RHEUMATOL, V25, P1
[8]   SJOGRENS SYNDROME - A CLINICAL PATHOLOGICAL AND SEROLOGICAL STUDY OF 62 CASES [J].
BLOCH, KJ ;
BUCHANAN, WW ;
WOHL, MJ ;
BUNIM, JJ .
MEDICINE, 1965, 44 (03) :187-+
[9]   SJOGRENS SYNDROME .1. SEROLOGIC REACTIONS IN PATIENTS WITH SJOGRENS SYNDROME WITH AND WITHOUT RHEUMATOID ARTHRITIS [J].
BLOCH, KJ ;
WOHL, MJ ;
SHIP, II ;
OGLESBY, RB ;
BUNIM, JJ .
ARTHRITIS AND RHEUMATISM, 1960, 3 (04) :287-297
[10]  
BOMBARDIERI S, 1989, CLIN EXP RHEUMATOL, V7, P111